Table I.
Clinical and laboratory patient information in control and patients with chronic lymphocytic leukaemia.
| Variable | Control | Upper-lower quartile | CLL patients | Upper-lower quartile | P-value |
|---|---|---|---|---|---|
| Age | 64 | 72–55 | 70.5 | 76–65 | 0.027 |
| Platelet (109/l) | 238.6 | 270–205 | 160.81 | 203–111 | <0.001 |
| Haemoglobin (g/l) | 13.93 | 15.3–12.7 | 12.23 | 14.1–10.9 | 0.001 |
| Leukocytes (109/l) | 7.61 | 8.86–5.87 | 68.59 | 89.62–24.44 | <0.001 |
| BMI | 27.52 | 29.72–25.56 | 27.32 | 29.75–24.35 | 0.430 |
| Comorbidities | |||||
| Anaemia | 1 (33.3%) | 19 (36.5%) | <0.001 | ||
| Low platelets | 3 (10.0%) | 23 (44.2%) | 0.001 | ||
| DM | 6 (20.0%) | 11 (21.2%) | 0.569 | ||
| CHD | 13 (43.3%) | 21 (40.4%) | 0.487 |
Data are presented as median (interquartile range) or mean ± standard deviation (SD). Paired t-test Fisher. DM, Diabetes mellitus; CHD, chronic heart disease, CLL, chronic lymphocytic leukemia. One-way analysis of variance with Bonferroni post-hoc test.